I think the latest days have been amazing for ZOM, Truforma is coming in Q121 and so other solutions in the pipeline, the prospects for the company are very good.
This team have been working for years and deserve a better company stock valuation now with their new developed technology.
For the short time, I think the stock is likely to retest the 200ma, perhaps around 12ish and consolidate, but I wouldn't get surprise if the stock shoots up to 20 cents or over.
This team have been working for years and deserve a better company stock valuation now with their new developed technology.
For the short time, I think the stock is likely to retest the 200ma, perhaps around 12ish and consolidate, but I wouldn't get surprise if the stock shoots up to 20 cents or over.